Your Window Into the Innovation Economy

If you’re raising capital as a preclinical biotech company today, the market is sending a clear signal: come back when you have more data. But that signal may be creating one of the more interesting investment opportunities in the sector right now.

University of California, Berkeley has quietly become the most prolific public university in the world for venture-backed founders, pairing elite engineering depth with a research-to-market pipeline that consistently produces breakout companies. From powering global leaders like Apple, Tesla, DoorDash, Databricks, and OpenAI to shaping the next generation of AI and deep tech startups, Berkeley’s founder ecosystem offers investors rare access to a compounding engine of innovation.